Cancer-therapy related endocrine toxicities are increasing with the increasing use of immune-modulating and targeted anti-cancer treatments. In this webinar we will discuss what an endocrinologist needs to know about these toxicities.
Planned speaker is Dr. L. Chaker, Endocrinologist, the Netherlands
Register now for the next ESE Talks…Sarcopenia in Rare Endocrine Disorders is planned for Tuesday, 3 March at 17:00-18:30 (CET).
Applications are now open for the 2026 Data, Ethics and AI training developed by EURORDIS and ERDERA, offering high-quality training for rare disease patient advocates and early-career researchers (PhD candidates and up to two years post-PhD).
This training has been developed in response to the growing need for advocates and researchers to understand and navigate the complexities of data management, ethical considerations, and the role of AI in rare disease research across Europe.
The online part of the training will run from March to July 2026, followed by the in-person sessions on 14–15 September 2026 in Barcelona.
[...]Find out about the application process and programme of the Rare Endocrine Disease Winter School, Varna, Bulgaria Saturday 28 Febuary – Tuesday, 3rd March, 2026. This RED Winter School will feature international speakers from Endo-ERN. A small group of a maximum of 30 participants will be treated to diverse sessions including lecturers, case presentations, roundtable discussions and plenty of time to interface with international experts.
Agenda topics will cover all Endo-ERN Main Thematic Groups (MTGs) providing a well rounded experience for those intersted in learning more about rare endocrine conditions.
Deadline for application is Monday, 12 [...]
Endo-ERN is deeply saddened to share the news of the passing of Jette Kristensen, a founding ePAG of Endo-ERN and long-standing board member and former chair of the Danish patient organisation Addison Foreningen Danmark.
Jette was a central figure in establishing patient representation within Endo-ERN. She helped ensure that the patient voice was embedded in the network from its very beginning and remained at the heart of collaboration, care, and decision-making in rare endocrine diseases.
Alongside her European work, Jette devoted nearly two decades to leadership within Addison Foreningen Danmark, serving with exceptional commitment. Through her [...]
As the year draws to a close, it is a great moment to look back on a set of clinical recommendations and best-practice guidelines, published earlier this year, that provide an important update on the diagnosis, management, and long-term care of Multiple Endocrine Neoplasia type 1 (MEN1). These guidelines bring together the latest evidence and expert consensus to support more consistent, high-quality care across centres.
The document emphasises that MEN1 is a complex, multi-tumour condition, and although genomic sequencing has improved the detection of MEN1 pathogenic variants, early clinical recognition remains [...]
The European Commission has published the first-ever Continuous Monitoring Report for the European Reference Networks (ERNs), covering the 2023–2024 reporting period. This milestone report compiles data from more than 1,600 clinical units across 375 hospitals in 27 EU Member States and Norway, offering the most comprehensive overview yet of ERN activity and impact since their launch in 2017.
The report presents detailed indicators across the ERN system’s seven core areas — clinical activity, cross-border collaboration (CPMS), registries, training, guidelines, dissemination and coordination — providing a clear picture of how ERNs support patients with rare diseases across Europe. It highlights a [...]
REGISTER NOW for the upcoming 2026 I-DSD Symposium scheduled 1-3 July, Lübeck, Germany.
Endo-ERN is pleased to endorse the 2026 I-DSD Symposium, bringing together global experts, clinicians, and patient representatives to advance care and research in DSD.
The three-day programme covers biological sex development, fertility preservation, quality of care benchmarking, hormones and athletic performance, innovations in hormone therapies, and surgical outcomes.
A half-day I-DSD Training Workshop on 1 July offers practical sessions on diagnostics, communication, hormone replacement, registries, and sex therapy.
Full agenda and [...]
